|
Cost-effectiveness of upfront therapeutic options in low-volume de novo metastatic hormone-sensitive prostate cancer. |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Stock and Other Ownership Interests - Gene Sciences |
Consulting or Advisory Role - Gene Sciences; Gene Sciences; PRogenics; PRogenics |
Research Funding - Janssen Scientific Affairs; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems |
Patents, Royalties, Other Intellectual Property - I am listed as inventor on patents related to PyIm polyamides that have been licensed by Gene Sciences |
| |
|
Consulting or Advisory Role - Johnson & Johnson |
Speakers' Bureau - Bayer; Johnson & Johnson |
Research Funding - Johnson & Johnson (Inst); Medivation/Astellas (Inst); Novartis (Inst) |
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a patent for novel inhibitors of the N-terminal domain of the AR. There are NO commercial partnerships as of yet. |
Travel, Accommodations, Expenses - Johnson & Johnson |
| |
|
Honoraria - Varian Medical Systems |
Consulting or Advisory Role - Intelligent Automation |
| |
|
|
Consulting or Advisory Role - Boston Scientific; Viewray; vision RT |
Travel, Accommodations, Expenses - Viewray |
| |
|
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics |
Research Funding - Janssen |
| |
|
Consulting or Advisory Role - Magellan Health |
| |
|
No Relationships to Disclose |
| |
|
Leadership - PFS Genomics |
Stock and Other Ownership Interests - Nutcracker Therapeutics, Inc.; PFS Genomics; SerImmune |
|
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Celgene; EMD Serono; Genzyme; Janssen Biotech; Medivation/Astellas |
Research Funding - Zenith Epigenetics |
Patents, Royalties, Other Intellectual Property - I helped develop a molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, my employer. It is in the process of being licensed to PFS Genomics, a company that I helped found. (Inst) |
| |
|
Consulting or Advisory Role - Blue Earth Diagnostics; Janssen Oncology |
| |
|
Stock and Other Ownership Interests - ImaginAb |
Consulting or Advisory Role - Astellas Pharma |
Speakers' Bureau - Genomic Health; ImaginAb; Janssen Oncology |
Patents, Royalties, Other Intellectual Property - patents surrounding discovery of PSCA and N-cadherin, owned by UCLA (Inst) |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Reflexion Medical |
Consulting or Advisory Role - Astellas Pharma; Dendreon; GenomeDx; Noxopharm; Reflexion Medical; Reflexion Medical; Regeneron |
Research Funding - Astellas Pharma (Inst); Bayer Health (Inst); Reflexion Medical (Inst) |
Patents, Royalties, Other Intellectual Property - Compounds and Methods of Use in Ablative Radiotherapy. Patent filed 3/9/2012. PCT/US2012/028475. PCT/WO/2012/122471. |
Travel, Accommodations, Expenses - Reflexion Medical |
| |
|
Honoraria - Varian Medical Systems; ViewRay; ViewRay |
Consulting or Advisory Role - Janssen |